Article Details
Retrieved on: 2021-07-12 16:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The findings from an interim analysis of the open-label APeX-S trial also supported Orladeyo's ability to reduce the frequency of HAE attacks, ease ...
Article found on: angioedemanews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here